Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Arvida Group (ARV) / HY26

Operating cash flow fell 44% as gross borrowings climbed to $1.0bn

Operating EBITDA was nearly flat but operating cash flow fell 44% and gross borrowings rose 34% to $1.0bn against a subdued property market.

Healthcare / Retirement living

ARV revenue trajectory

Revenue context before the current result.

↗
Loading chart...
FY26 was $262.7m, versus $131.9m in HY26.

ARV EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
FY26 was 50.6%, versus 33.1% in HY26.

ARV operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
FY26 was $107.8m, versus $44.7m in HY26.

ARV working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
FY26 was $1.1m, versus -$1.7m in HY26.
Release date
28 November 2025
Published
21 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

HY26 vs HY25

Revenue

$131.9m

+5.1% ↑ vs $125.5m

EBITDA

$43.7m

-0.9% ↓ vs $44.1m

Net profit after tax

−$8.2m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Net cash inflow from operating activities

$44.7m

-43.7% ↓ vs $79.5m

Profit before tax

−$8m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Cash and cash equivalents

$5.1m

+32.6% ↑ vs $3.9m

Total assets

$4.7b

+9.5% ↑ vs $4.3b

What changed

Operating revenue rose 5.1% to $131.9m, but Operating EBITDA slipped 0.9% to $43.7m

Net cash inflow from operating activities fell 43.7% to $44.7m from $79.5m, taking cash conversion (OCF/EBITDA) from 180.3% to 102.3%. Gross borrowings rose 33.9% to $1b, lifting net debt to roughly $1b and net debt/EBITDA (on annualised half-year EBITDA) to about 23.5x from 17.4x.

The headline swing from a $64.0m profit to an $8.2m loss is largely an investment-property revaluation effect: HY25 included a $72.9m fair value gain on investment property, while the current half ran without that tailwind against the "subdued" property market management noted in commentary. This is also Arvida's first half-year reporting as a debt-only issuer following the issuer transition.

What matters

Cash conversion deterioration

OCF/EBITDA fell from 180.3% to 102.3% even though EBITDA was essentially flat. The $34.8m year-on-year shortfall in operating cash reflects ORA settlement and working-capital timing rather than a profit shortfall, but it lands at a moment when the debt stack has grown materially. Cash to service that larger stack came in well below the comparable.

Leverage trajectory. Gross borrowings rose $260.5m while equity rose only $31.2m on a 9.5% larger asset base. The headline 23.5x net debt/EBITDA looks extreme but is partly an artefact of how EBITDA excludes resale and revaluation contributions in this sector; the directional move from 17.4x is what matters, particularly for a debt-only issuer where covenant headroom drives flexibility.

Underlying operating engine is steady. Revenue +5.1% on growth in deferred management fees and care/village services, with resale settlements 4% higher than HY25. Stripping out fair value movements, the recurring earnings base is broadly flat — the dramatic NPAT line is doing more work than the operating read warrants.

Expectations

No forward guidance or stated targets are supplied in this release

The FY25 shape shows H1 represented 49.5% of full-year revenue but only 43.7% of full-year Operating EBITDA — second-half weighted, with implied H2 FY25 EBITDA of $56.9m versus $44.1m in H1.

If the FY25 cadence repeats, full-year Operating EBITDA could again approach $100m. But reported NPAT is unlikely to benefit from a repeat of HY25's $72.9m fair value tailwind given the "subdued" property market commentary, so the reported earnings shape and the operating earnings shape will likely diverge again at year-end.

Quality of result

Operating quality is mixed

Revenue growth came from deferred management fees and care/village service revenues — durable, recurring streams — and receivable days improved to 25.6 from 29.4. But operating cash flow at $44.7m is sharply below the $79.5m comparable, and FCF (pre-lease) of $40.8m against a -$8.2m NPAT yields a -499.1% conversion that is not informative this half. Capex of $3.9m, just 3.0% of revenue, is light and likely reflects timing rather than a structural step-down.

The reported NPAT loss is overwhelmingly an accounting effect. The 2.0pp gap between PBT growth (-114.8%) and NPAT growth (-112.8%) is small, so this is not a tax distortion — it is the absence of the prior fair value gain on investment property flowing through both PBT and NPAT. The operating read sits with EBITDA, not the headline loss line, but the cash and leverage trajectory is the more economically material development this half.

Unresolved

Open questions

What drove the $34.8m drop in operating cash flow given EBITDA was flat — ORA settlement timing, refundable obligations, or other working-capital items?
How does management assess covenant headroom and refinancing risk on the $1.0bn gross debt stack now that Arvida reports as a debt-only issuer?
What fair value movement on investment property was recognised this half, and which valuation assumptions changed against the subdued market backdrop?
Will the H2-weighted EBITDA pattern from FY25 repeat, and what resale volume and pricing assumptions underpin that?
How does capital allocation change under the debt-only structure, particularly capex pacing and any internal return hurdles?

This briefing cannot assess covenant headroom, refinancing terms, or the specific fair value movement on investment property without those disclosures.

Chat

Ask about ARV HY26

Ask follow-up questions about Arvida Group's HY26 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about ARV HY26

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Arvida Group's HY26 result.

What drove the $34.8m drop in operating cash flow given EBITDA was flat — ORA settlement timing, refundable obligations, or other working-capital items?Why does "Cash conversion deterioration" matter?How strong was the cash and earnings quality in HY26?What should I watch next for ARV after HY26?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Interim Report

HY26 / financial report↗

Media Release

HY26 / media release↗

Results Announcement

HY26 / results announcement↗

Prior comparable period

Interim Report

HY25 / financial report↗

Media Release

HY25 / media release↗

Results Announcement

HY25 / results announcement↗

Full-year context

Arvida Group Limited - 2025 Consolidated Financial Statements (Audited)

FY25 / financial report↗

FY25 Results Announcement (NZX Prescribed Release)

FY25 / results announcement↗

FY25 Results Market Release

FY25 / results release↗

Related insights

Cross-company views selected from the metrics in this briefing.

Cash conversion quality

This result converted 102.3% of EBITDA to operating cash flow, -77.9pp versus the prior comparable period.

→

Leverage and balance-sheet risk

Net debt / EBITDA is 23.46x, +6.10x versus the prior comparable period.

→

Earnings quality and statutory distortions

This result includes a statutory earnings-quality distortion flag.

→

Revenue growth context

Revenue growth was 5.1% for this reporting period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when ARV publishes next

Get the next Arvida Group briefing and related NZX reporting-season updates by email.